
Advancements in Hemophilia Management: Addressing the Challenges of Inhibitors and Exploring Novel Therapeutic Strategies
Abstract Hemophilia, a severe, X-linked recessive bleeding disorder, stems from deficient or dysfunctional coagulation factors VIII (FVIII) in hemophilia A or factor IX (FIX) in hemophilia B. While factor replacement therapy has revolutionized patient outcomes, […]